Current Statistics On Pancreas Life Expectancy Offers Little Hope
Once a person has been diagnosed with pancreatic cancer, the pancreas cancer life expectancy is extremely low. In general, most doctors estimate that a patient will live only five to eight months. Approximately 20% of pancreatic cancer patients may live for at least one year after diagnosis. The percentage is even less for patients who live beyond this time frame. Only about 5% will live for more than five years. These startling statistics leave no confusion of why pancreas cancer is the second leading cause of death in the world. In the United States, approximately 1% of the population dies from this type of cancer. This may seem like a small number, but in fact, it surpasses the number of deaths from other diseases such as HIV/AIDS.
Why is Pancreas cancer life expectancy so Low?
The primary reason surrounding a low life expectancy for pancreatic cancer patients is because of the pancreas. This organ is hidden in the body and is difficult to reach, even for a highly skilled surgeon. The location makes it harder for doctors to see the tumors, making early diagnosis hard to accomplish. Additionally, the pancreatic tumors can spread rapidly, even with early detection, and get into areas of the body where removing them become virtually impossible.
People who experience a longer pancreas cancer life expectancy are those with pancreatic tumors that have not spread to more dangerous areas of the body. Surgery also helps, where parts of the pancreas and tumors are removed. However, only 16% of these patients are expected to life longer than five years after surgery. Unfortunately, research has not advanced for us to know how a person may avoid getting pancreatic cancer. The symptoms can appear to be other health conditions. Some studies reveal that nonsmokers are less at risk for getting this or any other type of cancer. Maintaining a healthy lifestyle by eating the right foods and exercising may help, although these are habits that in which everyone should partake to avoid other serious illnesses.
Research for pancreatic cancer is currently poorly funded in the United States, which hinders finding a cure and increasing the pancreas cancer life expectancy for patients. The more attention that is brought to this matter, perhaps will lead to more being done to reverse some of the dismal statistics of pancreatic cancer. Until that time, we must remain optimistic and do everything within our power to try and avoid the onset of this deadly disease.